LIWANLI Innovation Co., Ltd. (TPE:3054)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biotechnology	44.02M	38.77M	34.10M	33.88M	47.45M
Biotechnology Growth	13.56%	13.68%	0.64%	-28.59%	-25.35%
Electronics	81.52M	60.39M	4.79M	105.00K	367.00K
Electronics Growth	34.98%	1161.30%	4460.00%	-71.39%	-99.83%
Total	125.54M	99.16M	38.89M	33.99M	47.81M
Total Growth	26.61%	154.98%	14.41%	-28.91%	-82.73%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	105.38M	71.73M	37.49M	33.27M	32.51M
Taiwan Growth	46.91%	91.33%	12.67%	2.34%	-86.63%
Other	20.17M	27.43M	1.40M	715.00K	15.30M
Other Growth	-26.48%	1863.35%	95.38%	-95.33%	-54.57%
Total	125.54M	99.16M	38.89M	33.99M	47.81M
Total Growth	26.61%	154.98%	14.41%	-28.91%	-82.73%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error